유방암에서 HER2/ neu 유전자 정량과 MAGE 검사의 임상적 의의

참고문헌 (30)

1. "The neu gene:an erbB-homologous gene distinctfrom and unlinked to the gene encoding the EGF receptor", 229, pp.976~8 (1985)
2. "Theproduct of the human c-erbB-2 gene:a 185-kilodalton glycoproteinwith tyrosine kinase activity", 232, pp.1644~6 (1986)
3. "TheHer-2", neu gene and protein in breast cancer 2003:biomarker andtarget of therapy, 2003, pp.8, 307~325
4. "Studies of the HER-2", neu proto-oncogene in human breast andovarian cancer, 1989, pp.244, 707~12
5. "C-ERBB-2 gene amplification as a prognostic marker inhuman bladder cancer", 55, pp.679~683 (2000)
6. "Expression and gene copy number analysis of ERBB2 oncogenein prostate cancer", 160, pp.339~345 (2002)
7. "Human breast cancer:correlation of relapse and survival with amplificationof the HER-2", neu oncogene, 1987, pp.235, 177~82
8. "c-erbB-2(HER-2", neu)gene amplification is a betterindicator of poor prognosis than protein over-expression in operablebreast-cancer patients, 2001, pp.95, 266~270
9. "Prognosticvalue of c-erbB2 expression in breast cancer", 79, pp.216~223 (2002)
10. "Testing for HER2 status", 61(2), pp.22~30 (2001)
11. "Emerging technologies for HER2 testing", 63(1), pp.33~38 (2002)
12. "Current perspectives on HER2 testing:a review of national testingguidelines", 16, pp.173~182 (2003)
13. "Quantificationof HER2", neu gene amplification by competitive PCR using fluorescentmelting curve analysis, 2001, pp.47, 844~851
14. "HER2", neugene copy number quantified by real-time PCR:comparison of gene amplification,heterozygosity,and immunohistochemical status inbreast cancer tissue, 2003, pp.49, 219~229
15. "Real-time reverse transcription-PCR assay for future managementof ERBB2-based clinical applications", 45, pp.1148~1156 (1999)
16. "Structure,chromosomal localization,and expression of 12genes of the MAGE family", 40, pp.360~9 (1994)
17. "MAGE-A gene expression pattern in primary breast cancer", 61, pp.6682~6687 (2001)
18. "Expression of MAGE tumour-associated antigens isinversely correlated with tumour differentiation in invasive ductalbreast cancers:an immunohistochemical study", 439, pp.127~131 (2001)
19. "Evaluating HER2 amplification and overexpression in breastcancer", 195, pp.422~428 (2001)
20. "Comparisonof fluorescence in situ hybridization and immunohistochemistry forthe evaluation of HER-2", neu in breast cancer, 1999, pp.17, 1974~1982
21. "유방암 환자에서 면역조직화학염색을 이용한 c-erbB-2 단백 발현의 연구", 62, pp.456~462 (2002)
22. "유암 환자에서 예후인자로서 C-erbB-2 단백발현의 의의", 55, pp.44~51 (1998)
23. "Evaluation of HER2", neu status by real-time quantitative PCR in breast cancer, 2002, pp.43, 335~340
24. "Comparative methodological analysis of erbB-2", HER-2 gene dosage,chromosomal copy number and protein overexpressionin breast carcinoma tissues for diagnostic use, 2000, pp.37, 411~419
25. "Detection of gene amplification in archival breast cancer specimensby laser-assisted microdissection and quantitative real-timepolymerase chain reaction", 156, pp.1855~1864 (2000)
26. "p185-HER2 overexpression in human breast cancer using molecular andimmunohistochemical methods", 18, pp.336~342 (2000)
27. "Quantitative association between HER-2", neu and steroidhormone receptors in hormone receptor-positive primary breastcancer, 2003, pp.95, 142~153
28. "Expression ofMAGE and BAGE genes in Japanese breast cancers", 8, pp.369~372 (1997)
29. "종양세포 검출을위한 MAGE A1-6 역전사 이중 중합효소연쇄반응법의 민감도 및특이도 평가", 23, pp.357~362 (2003)
30. "A newstrategy for the diagnosis of MAGE-expressing cancers", 266, pp.79~86 (2002)

관련 논문AI추천